Satellite Symposium
Prolonging Survival in Multiple Myeloma:
Balancing the Efficacy of Maintenance Therapy with Long-Term Safety
A Case-Based, Roundtable Discussion. A Luncheon Symposium during the 2011 Lymphoma & Myeloma Congress
Date and Location
October 21, 2011
New York, New York
The Waldorf=Astoria
301 Park Avenue
New York, New York 10022
Tel.: +1 (212) 355 3000
Fax: +1 (212) 872 7272
Reservation: (877) 476 8792
www.waldorf.com
Symposium Chair
Ruben Niesvizky, MD
Center for Lymphoma and Myeloma
Weill Cornell Medical College
New York-Presbyterian Hospital/
Weill Cornell Medical Center
New York, New York
Continuing Medical Education
Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex®, LLC designates this live educational activity for a maximum 1.5 of AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Who Should Attend
This educational activity is specifically designed for hematologists, oncologists, and other health-care professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved and/or interested in the therapeutic management of patients with multiple myeloma.
Objectives
after successful completion of this course, participants should be able to have:
- Increased frequency of plans to consider maintenance therapy for myeloma patients who are responding to frontline or salvage treatment
- Increased confidence in ability to recommend appropriate maintenance strategies for myeloma patients based on age, comorbidities, risk status, and other factors
- Increased confidence in ability to navigate practical issues associated with maintenance therapy for multiple myeloma
Faculty
Kenneth C. Anderson, MD
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts
Joseph Mikhael, MD
Associate Professor
Mayo Clinic Arizona
Scottsdale, Arizona
Antonio Palumbo, MD
University of Torino
Torino, Italy
Corporate Support
The following company has provided an educational grant in support of this symposium:
Scientific Agenda
11:30 am
Lunch served
11:40 am
Introduction of faculty panel and pre-activity audience assessment via ARS
Ruben Niesvizky, MD
11:45 am
Case 1: Standard-risk patient with normal cytogenetics achieves CR after transplant
Kenneth C. Anderson, MD
12:05 pm
Case 2: High-risk patient with residual disease after transplant
Ruben Niesvizky, MD
12:25 pm
Case 3: Young patient is on maintenance for 2 years then relapses
Joseph Mikhael, MD
12:45 pm
Case 4: Patient has good response to maintenance but high risk for secondary cancers
Antonio Palumbo, MD
1:05 pm
Panel consensus take-home message and post-activity audience assessment via ARS
1:10 pm
Adjourn
Symposium Registration
Registration is complimentary to attendees of the Lymphoma & Myeloma 2011 Congress.
Symposium Organizer
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
www.imedex.com